StockData

RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3076% below fair value
$4.83−0.47 (-8.87%)

Close on Nov 17, 2026Market cap $200.90MP/E –Yield –

RxSight pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

RxSight's pe ratio was 1.3× on Oct 29, 2021.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2021Oct 29, 20211.3×–

More RxSight figures

See a number that looks wrong?